Related Experiment Video
Updated: Jul 9, 2026

Translationally-Relevant Tumor Resection Model for Murine Preclinical Models of Oral Squamous Cell Carcinoma
Published on: April 3, 2026
Gene therapy in head and neck cancer: a review
E Chisholm1, U Bapat, C Chisholm
1Molecular Oncology, Cancer Research UK, Barts and The London NHS Trust, London, UK. edwardchisholm@doctors.org.uk
Abstract:
Gene therapy for cancer is a rapidly evolving field with head and neck squamous cell cancer being one of the more frequently targeted cancer types. The number of clinical trials in the UK is growing and there is already a commercially available agent in China. Various gene therapy strategies along with delivery mechanisms for targeting head and neck cancer are reviewed.
Insights
Gene therapy shows promise for head and neck squamous cell cancer. This review covers evolving strategies and delivery methods, with growing clinical trials and existing treatments in China.
Area of Science:
- Oncology
- Molecular Biology
- Biotechnology
Background:
- Head and neck squamous cell cancer (HNSCC) is a significant global health concern.
- Gene therapy is an emerging modality for cancer treatment.
- HNSCC is a frequently targeted cancer type for gene therapy interventions.
Purpose of the Study:
- To review current gene therapy strategies for HNSCC.
- To discuss various delivery mechanisms for gene therapy in HNSCC.
- To highlight the evolving landscape of HNSCC gene therapy research and clinical application.
Main Methods:
- Literature review of gene therapy approaches for HNSCC.
- Analysis of clinical trial data and commercially available agents.
- Synthesis of information on gene therapy strategies and delivery systems.
Main Results:
- Gene therapy for HNSCC is a rapidly advancing field.
- The number of clinical trials in the UK is increasing.
- A commercially available gene therapy agent for HNSCC exists in China.
Conclusions:
- Gene therapy holds significant potential for treating HNSCC.
- Continued research and development in gene therapy strategies and delivery are crucial.
- The global progress in HNSCC gene therapy, including clinical trials and market approvals, indicates a promising future.
Related Concept Videos
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Tumor Immunotherapy
Treatment Resistant Cancers
Treatment Resistent Cancers
